CONTEXT: Neuroblastoma is the most common extracranial malignant solid tumor that occurs during childhood. It arises from primitive cells and is seen in the adrenal medulla and sympathetic ganglia of the sympathetic nervous system. CASE REPORT: We present a rare case of a 40-year-old man who was diagnosed with the onset of neuroblastoma arising in the mediastinum. He was treated by means of surgical resection in the superior mediastinum after neoadjuvant chemotherapy.
INTRODUCTION
Neuroblastomas are the most common extracranial malignant solid tumors that occurs during childhood. They arise from primitive cells and are seen in the adrenal medulla and sympathetic ganglia of the sympathetic nervous system. These aggressive cells begin to grow uncontrollably.
Neuroblastomas may lead to signs such as swelling in the face, neck, arms and upper chest, headaches, dizziness, changes to consciousness, drooping eyelids and small pupils. They may also lead to signs of paraneoplastic syndromes that include constant diarrhea, fever, high blood pressure (causing irritability), rapid heartbeat, flushing of the skin and sweating. Because neuroblastomas consist of embryonic cells, they are especially common among small children: up to 90% of the patients are younger than six years old. On the other hand, neuroblastomas are only rarely seen in older children and adults. Incidence rates of one case per 100,000 children per year and one case per 10 million adults per year have been reported. 1, 2 The most common locations in adults are the chest, pelvis and neck. 2 Approximately 20% of the cases occur in the mediastinum. 2 Multimodal treatments are used, including surgery, chemotherapy and radiotherapy. No standard treatment protocol has been developed for adults. Thus, the same protocol is used for adults and children. In adults, the disease presents much more aggressively than in children. 2 Here, we present a rare case of neuroblastoma in an adult, which was treated by means of neoadjuvant chemotherapy and surgery.
CASE REPORT
A 40-year-old male patient was hospitalized with complaints of anorexia, fatigue, headache and weight loss. Physical examination and routine blood tests were unremarkable. Chest x-ray detected a right paratracheal lesion. The following tumor markers were all negative: carcinoembryonic antigen, carbohydrate antigen 19-9, alpha fetoprotein and vanillylmandelic acid, as also were urine tests. Lactate dehydrogenase and neuron-specific enolase blood levels were also within normal limits. Catecholamine metabolites were not found to be elevated in 24-hour urine collection. 
DISCUSSION
Neuroblastoma is a very common childhood disease, but it is rarely detected in adolescents and adults. The most important clinically relevant factors that influence survival among these patients are stage, age, histology and tumor grade. Young age and low stage with timely diagnosis are two important favorable prognostic features. 3 Whereas five-year overall survival is 85% for infants, it is only 36% for adults. However, it became possible to completely resect the tumor after it regressed, through NCT.
Tumors categorized as neuroblastoma have been further divided into three subtypes: undifferentiated, poorly differentiated and differentiated, based on their degree of neuroblastic differentiation. 4 Presence of Schwannian stroma in neuroblastomas is related to patient prognosis. Our case was identified as the poorly-differentiated stroma-poor Schwannian subtype.
Conter et al. 5 compared neuroblastoma cases in 118 adults (mean age of 47 years) and 112 children (mean age of 5 years). For all stagematched categories, the prognoses for the adult patients were not statistically different from those of the pediatric neuroblastoma patients.
A search of the literature in major medical databases for case reports on neuroblastoma, neuroblastoma in adults and mediastinal neuroblastoma is presented in Table 1 . 
CONCLUSION

